The purpose of this study is to determine the safety and effectiveness of combination therapy with Proleukin and Rituxan on patients with intermediate-and high- grade Non-Hodgkin's lymphoma.
Inclusion:
Exclusion:
Washington D.C., District of Columbia 20007, United States
Miami, Florida 333136, United States
Shreveport, Louisiana 71130, United States
The Bronx, New York 10466, United States
Greenville, North Carolina 27858, United States